Product Images Calcarea Fluorica

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 4 images provide visual information about the product associated with Calcarea Fluorica NDC 15631-0095 by Rxhomeo Private Limited D.b.a. Rxhomeo, Inc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Label Pellets FDA 15631 0095

Label Pellets FDA 15631 0095

This is a description of a homeopathic medication called CALCAREA FLUORICA 3X. The ingredients include active and inactive components, and it is manufactured by a company in India. The medication is intended for temporary relief of boils, with recommended dosages for adults and children over 2 years old. The product is for self-treatment but should not be used for over 4 days without improvement or if symptoms worsen. It is important to seek advice from a healthcare professional before using this product if pregnant or nursing. The medication comes in a pack of 100 pellets, and proper storage is recommended.*

Mini Labels Pellets FDA15631 0095

Mini Labels Pellets FDA15631 0095

This is a description of a homeopathic medication containing an active ingredient called "Calcarea Fluorica 3X A %" and an inactive ingredient named "Sucrose". The medication is used for temporary relief with a suggested dosage of 4 pellets taken orally three times a day for adults and half that dosage for children above two years. It comes in a blister pack with a mini-label and some information displayed on it such as the NDC and some manufacturing information.*

Rxhomeo Secondary Packing Blister Pack

Rxhomeo   Secondary Packing   Blister Pack

Rxhomeo Secondary Packing Carton Pack

Rxhomeo   Secondary Packing   Carton Pack

This is a description for Homeopathic Medicine. The product is a single homeopathic remedy that is lactose-free and manufactured according to the Homoeopathic Pharmacopoeia of the United States (HPUS). This medicine should not be used for serious medical conditions, and a healthcare professional should be contacted if symptoms persist or worsen after 4 days of use. The warning advises against use if pregnant or nursing. The labels and secondary packing specimens will feature the manufacturer's address in India unless confidential. A primary packaging will be used based on the pack size/contents. If the bottle/container is small, a secondary packing, such as a Carton box or a Blister pack, will be used.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.